4.5 Article

Paternal age and specific neurological soft signs as reliable and valid neurobiological markers for the diagnosis of patients with schizophrenia

期刊

出版社

SPRINGER HEIDELBERG
DOI: 10.1007/s00406-021-01357-6

关键词

Parental; Paternal; Maternal; Neurological soft signs; Schizophrenia; Neurological abnormalities

向作者/读者索取更多资源

This study aimed to develop a neurobiological diagnostic index by combining advanced parental age at delivery and neurological soft signs, without considering clinical symptoms. The findings suggest that the Psychotic Neurological Index may serve as an easily obtainable diagnostic neurobiological marker with identifiable properties to distinguish patients with schizophrenia from healthy controls with high efficacy.
Advanced parental age at delivery and neurological soft signs (NSS) constitute risk factors for schizophrenia. The aim of the current study was to develop a neurobiological diagnostic index by combining them, and without the contribution of clinical symptomatology. The study sample included 133 patients suffering from schizophrenia according to DSM-IV-TR (77 males and 56 females; aged 33.55 +/- 11.22 years old) and 122 normal controls (66 males and 56 females; aged 32.89 +/- 9.91 years old). The assessment included the Neurological Evaluation Scale (NES), and a number of scales assessing the clinical symptoms and adverse effects. The statistical analysis included exploratory t-test, Pearson Correlation coefficient (R) and Discriminant Function Analysis (DFA). Exploratory t-tests and Pearson's R suggested that sex, parental age and NSS constitute independent components. On the basis of DFA results, the Psychotic Neurological Index was developed. At the cut-off PNI score of 8.5, sensitivity was equal to 94.74 and specificity to 93.44. The current is probably the first study to report on an easily obtainable diagnostic neurobiological marker with identifiable properties which is absolutely independent from the clinical manifestations and could serve in distinguishing between patients with schizophrenia and healthy controls with high efficacy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据